Sup19 CAR-T
IIT2025126
Phase 1 mab active
Quick answer
Sup19 CAR-T for B-Acute Lymphoblastic Leukemia is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- B-Acute Lymphoblastic Leukemia
- Phase
- Phase 1
- Modality
- mab
- Status
- active